Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-01-03 Sale |
2022-01-14 6:14 pm |
Voyager Therapeutics Inc. | VYGR | Burek Julie VP, Finance |
3,328 | $2.8483 | $9,479 | 46,257 (Direct) |
View |
2021-05-21 Sale |
2021-05-25 4:31 pm |
Voyager Therapeutics Inc. | VYGR | Khwaja Omar See remarks |
3,516 | $4.03 | $14,169 | 120,509 (Direct) |
View |
2021-04-05 Sale |
2021-04-07 5:44 pm |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
3,292 | $4.95 | $16,295 | 110,056 (Direct) |
View |
2021-02-11 Sale |
2021-02-16 4:11 pm |
Voyager Therapeutics Inc. | VYGR | Turenne Andre President & CEO |
7,977 | $7.55 | $60,226 | 148,375 (Direct) |
View |
2021-02-11 Sale |
2021-02-16 4:10 pm |
Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer |
3,186 | $7.55 | $24,054 | 45,894 (Direct) |
View |
2021-02-11 Sale |
2021-02-16 4:08 pm |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
3,186 | $7.55 | $24,054 | 49,348 (Direct) |
View |
2021-02-11 Sale |
2021-02-16 4:06 pm |
Voyager Therapeutics Inc. | VYGR | Khwaja Omar See remarks |
3,475 | $7.55 | $26,236 | 53,025 (Direct) |
View |
2021-01-12 Sale |
2021-01-14 5:59 pm |
Voyager Therapeutics Inc. | VYGR | Turenne Andre President & CEO |
10,443 | $8.62 | $90,019 | 156,352 (Direct) |
View |
2021-01-12 Sale |
2021-01-14 5:57 pm |
Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer |
2,942 | $8.62 | $25,360 | 49,080 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-02-07 Option Award |
2022-02-09 4:27 pm |
N/A 2032-02-07 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred Director |
44,000 | $0 | 44,000 (Direct) |
View |
Ownership |
2022-02-09 4:26 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
0 | $0 | 254,500 (Direct) |
View |
2022-01-13 Option Award |
2022-01-18 8:06 pm |
N/A 2032-01-13 |
Voyager Therapeutics Inc. | VYGR | Burek Julie VP, Finance |
50,000 | $0 | 96,257 (Direct) |
View |
2022-01-13 Option Award |
2022-01-18 8:06 pm |
N/A 2032-01-13 |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
140,000 | $0 | 250,056 (Direct) |
View |
2022-01-13 Option Award |
2022-01-18 8:05 pm |
N/A 2032-01-13 |
Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Interim CSO Director |
76,300 | $0 | 81,300 (Direct) |
View |
2022-01-13 Option Award |
2022-01-18 8:04 pm |
N/A 2032-01-13 |
Voyager Therapeutics Inc. | VYGR | Higgins Michael J Interim President & CEO |
206,205 | $0 | 206,205 (Direct) |
View |
2021-12-31 Option Award |
2022-01-14 6:14 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Burek Julie VP, Finance |
3,063 | $2.3 | 46,257 (Direct) |
View |
2021-11-26 Option Award |
2021-11-30 4:34 pm |
N/A 2031-11-26 |
Voyager Therapeutics Inc. | VYGR | Burek Julie VP, Finance |
38,500 | $0 | 71,522 (Direct) |
View |
Ownership |
2021-11-30 4:33 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Burek Julie Vice President, Finance |
0 | $0 | 87,382 (Direct) |
View |
2021-06-07 Option Award |
2021-06-08 4:09 pm |
N/A 2031-06-07 |
Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Interim CSO Director |
42,000 | $0 | 42,000 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 4:34 pm |
N/A 2031-06-03 |
Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 4:34 pm |
N/A 2031-06-03 |
Voyager Therapeutics Inc. | VYGR | PAUL STEVEN M Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 4:33 pm |
N/A 2031-06-03 |
Voyager Therapeutics Inc. | VYGR | Hyman Steven Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 4:32 pm |
N/A 2031-06-03 |
Voyager Therapeutics Inc. | VYGR | Higgins Michael J Interim President & CEO |
115,000 | $0 | 115,000 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 4:32 pm |
N/A 2031-06-03 |
Voyager Therapeutics Inc. | VYGR | LEVIN MARK J Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 4:32 pm |
N/A 2031-06-03 |
Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 4:31 pm |
N/A 2031-06-03 |
Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Interim CSO Director |
50,000 | $0 | 50,000 (Direct) |
View |
2021-03-19 Option Award |
2021-03-23 4:12 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Khwaja Omar See Remarks |
35,000 | $0 | 124,025 (Direct) |
View |
2021-03-19 Option Award |
2021-03-23 4:11 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
30,000 | $0 | 113,348 (Direct) |
View |
2021-03-19 Option Award |
2021-03-23 4:10 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Turenne Andre President & CEO |
80,000 | $0 | 322,375 (Direct) |
View |
2021-03-19 Option Award |
2021-03-23 4:10 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer |
30,000 | $0 | 109,894 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 4:59 pm |
N/A 2031-02-16 |
Voyager Therapeutics Inc. | VYGR | Turenne Andre President & CEO |
283,000 | $0 | 431,375 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 4:58 pm |
N/A 2031-02-16 |
Voyager Therapeutics Inc. | VYGR | Khwaja Omar See Remarks |
108,000 | $0 | 161,025 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 4:57 pm |
N/A 2031-02-16 |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
102,000 | $0 | 151,348 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 4:55 pm |
N/A 2031-02-16 |
Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer |
102,000 | $0 | 147,894 (Direct) |
View |
2020-09-15 Option Award |
2020-09-16 4:17 pm |
N/A 2030-09-15 |
Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director |
30,000 | $0 | 30,000 (Direct) |
View |
2020-06-04 Option Award |
2020-06-05 4:18 pm |
N/A 2030-06-04 |
Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director |
15,000 | $0 | 15,000 (Direct) |
View |
2020-06-04 Option Award |
2020-06-05 4:17 pm |
N/A 2030-06-04 |
Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director |
15,000 | $0 | 15,000 (Direct) |
View |
2020-06-04 Option Award |
2020-06-05 4:17 pm |
N/A 2030-06-04 |
Voyager Therapeutics Inc. | VYGR | Hyman Steven Director |
15,000 | $0 | 15,000 (Direct) |
View |
2020-06-04 Option Award |
2020-06-05 4:17 pm |
N/A 2030-06-04 |
Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director |
15,000 | $0 | 15,000 (Direct) |
View |